Treatment of pure red-cell aplasia following major ABO-mismatched T-cell-depleted bone marrow transplantation
β Scribed by R. Or; E. Naparstek; N. Mani; S. Slavin
- Publisher
- Springer
- Year
- 1991
- Tongue
- English
- Weight
- 442 KB
- Volume
- 4
- Category
- Article
- ISSN
- 0934-0874
No coin nor oath required. For personal study only.
β¦ Synopsis
Major ABO-mismatched bone marrow transplantation (BMT) may be accompanied by red-cell haemolysis, but pure red-cell aplasia following BMT is a rare complication. Two cases of transient pure red-cell aplasia following T-lymphocyte-depleted BMT for a period of greater than 20 weeks are described, both of which responded to one cycle of plasmapheresis. The prompt response of the two patients described with red-cell aplasia with no evidence of haemolysis suggests that plasmapheresis may be considered in such clinical situations as a first treatment of choice before attempting more complex modes of therapy.
π SIMILAR VOLUMES
We investigated the adoptive transfer of immunity to herpes simplex virus (HSV) in 61 recipients of T-cell-depleted marrow allografts. Up to 3 months after bone marrow transplantation (BMT), high titres of HSV antibody (Ab) are passively acquired from blood products. This antibody has a half-life of
## Abstract Previous work by Grob et al. [__Lancet__ i:774, 1987] has demonstrated that allogeneic, Tβcellβdepleted bone marrow transplant recipients have a better prognosis for reactivated cytomegalovirus (CMV) infection if their donor is also immune. It was proposed that adoptively transferred hu